Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

NCT01052298 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Disease, Pulmonary

Interventions

DRUG: Ciprofloxacin (Cipro inhale, BAYQ3939)
DRUG: Ciprofloxacin (Cipro inhale, BAYQ3939)
DRUG: Ciprofloxacin (Cipro inhale, BAYQ3939)
DRUG: Placebo

Sponsor

Bayer

Collaborators

[object Object]